167 related articles for article (PubMed ID: 31136207)
21. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
[TBL] [Abstract][Full Text] [Related]
22. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
Teisner AS; Ainsworth MA; Brynskov J
Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
[TBL] [Abstract][Full Text] [Related]
23. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
[TBL] [Abstract][Full Text] [Related]
24. Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study.
Kim EH; Kim DH; Park SJ; Hong SP; Kim TI; Kim WH; Cheon JH
Gut Liver; 2015 Sep; 9(5):601-6. PubMed ID: 25473080
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patients.
Angelison L; Almer S; Eriksson A; Karling P; Fagerberg U; Halfvarson J; Thörn M; Björk J; Hindorf U; Löfberg R; Bajor A; Hjortswang H; Hammarlund P; Grip O; Torp J; Marsal J; Hertervig E;
Aliment Pharmacol Ther; 2017 Feb; 45(4):519-532. PubMed ID: 28025840
[TBL] [Abstract][Full Text] [Related]
26. Analysis of colectomy rates for ulcerative colitis in pre- and postbiological eras in Lothian, Scotland.
Jenkinson PW; Plevris N; Lyons M; Grant R; Fulforth J; Kirkwood K; Arnott ID; Wilson D; Watson AJM; Jones GR; Lees CW
Colorectal Dis; 2021 May; 23(5):1175-1183. PubMed ID: 33350054
[TBL] [Abstract][Full Text] [Related]
27. Short term colectomy rate and mortality for severe ulcerative colitis in the last 40 years. Has something changed?
Clemente V; Aratari A; Papi C; Vernia P
Dig Liver Dis; 2016 Apr; 48(4):371-5. PubMed ID: 26854257
[TBL] [Abstract][Full Text] [Related]
28. Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients.
Costello SP; Ghaly S; Beswick L; Pudipeddi A; Agarwal A; Sechi A; O'Connor S; Connor SJ; Sparrow MP; Bampton P; Walsh AJ; Andrews JM;
Intern Med J; 2015 Jun; 45(6):659-66. PubMed ID: 25732268
[TBL] [Abstract][Full Text] [Related]
29. Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
Monterubbianesi R; Aratari A; Armuzzi A; Daperno M; Biancone L; Cappello M; Annese V; Riegler G; Orlando A; Viscido A; Meucci G; Gasbarrini A; Guidi L; Lavagna A; Sostegni R; Onali S; Papi C; Kohn A;
J Crohns Colitis; 2014 Aug; 8(8):852-8. PubMed ID: 24472490
[TBL] [Abstract][Full Text] [Related]
30. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients.
Molnár T; Farkas K; Nyári T; Szepes Z; Nagy F; Wittmann T
J Gastrointestin Liver Dis; 2011 Dec; 20(4):359-63. PubMed ID: 22187700
[TBL] [Abstract][Full Text] [Related]
31. Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.
Taxonera C; Barreiro-de Acosta M; Calvo M; Saro C; Bastida G; Martín-Arranz MD; Gisbert JP; García-Sánchez V; Marín-Jiménez I; Bermejo F; Chaparro M; Ponferrada Á; Martínez-Montiel MP; Pajares R; de Gracia C; Olivares D; Alba C; Mendoza JL; Fernández-Blanco I
Dig Dis Sci; 2015 Oct; 60(10):3075-84. PubMed ID: 26044830
[TBL] [Abstract][Full Text] [Related]
32. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
33. Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
Sebastian S; Myers S; Argyriou K; Martin G; Los L; Fiske J; Ranjan R; Cooper B; Goodoory V; Ching HL; Jayasooriya N; Brooks J; Dhar A; Shenoy AH; Limdi JK; Butterworth J; Allen PB; Samuel S; Moran GW; Shenderey R; Parkes G; Lobo A; Kennedy NA; Subramanian S; Raine T
Aliment Pharmacol Ther; 2019 Sep; 50(6):675-683. PubMed ID: 31456297
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study.
Mocciaro F; Renna S; Orlando A; Rizzuto G; Sinagra E; Orlando E; Cottone M
J Crohns Colitis; 2012 Jul; 6(6):681-6. PubMed ID: 22398101
[TBL] [Abstract][Full Text] [Related]
35. Early Changes in Serum Albumin Predict Clinical and Endoscopic Outcomes in Patients With Ulcerative Colitis Starting Anti-TNF Treatment.
Lee SH; Walshe M; Oh EH; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Greener T; Weizman AV; Silverberg MS; Ye BD
Inflamm Bowel Dis; 2021 Aug; 27(9):1452-1461. PubMed ID: 33269403
[TBL] [Abstract][Full Text] [Related]
36. Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
Taxonera C; Iglesias E; Muñoz F; Calvo M; Barreiro-de Acosta M; Busquets D; Calvet X; Rodríguez A; Pajares R; Gisbert JP; López-Serrano P; Pérez-Calle JL; Ponferrada Á; De la Coba C; Bermejo F; Chaparro M; Olivares D; Alba C; Fernández-Blanco I
Dig Dis Sci; 2017 Feb; 62(2):481-490. PubMed ID: 27995400
[TBL] [Abstract][Full Text] [Related]
37. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
Yamamoto-Furusho JK; Uzcanga LF
Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
[TBL] [Abstract][Full Text] [Related]
38. Treatment of acute ulcerative colitis with infliximab, a retrospective study from three Danish hospitals.
Mortensen C; Caspersen S; Christensen NL; Svenningsen L; Thorsgaard N; Christensen LA; Bendtsen F
J Crohns Colitis; 2011 Feb; 5(1):28-33. PubMed ID: 21272801
[TBL] [Abstract][Full Text] [Related]
39. Similar Short- and Long-term Colectomy Rates with Ciclosporin and Infliximab Treatment in Hospitalised Ulcerative Colitis Patients.
Duijvis NW; Ten Hove AS; Ponsioen CI; van den Brink GR; Buskens CJ; Bemelman WA; Te Velde AA; D'Haens GR; Löwenberg M
J Crohns Colitis; 2016 Jul; 10(7):821-7. PubMed ID: 26818660
[TBL] [Abstract][Full Text] [Related]
40. Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study.
Sjöberg M; Walch A; Meshkat M; Gustavsson A; Järnerot G; Vogelsang H; Hertervig E; Novacek G; Friis-Liby I; Blomquist L; Angelberger S; Karlen P; Grännö C; Vilien M; Ström M; Verbaan H; Hellström PM; Dejaco C; Magnuson A; Halfvarson J; Reinisch W; Tysk C
Inflamm Bowel Dis; 2012 Feb; 18(2):212-8. PubMed ID: 21438096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
